Literature DB >> 2429307

Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats.

A A Demetriou, S M Levenson, P M Novikoff, A B Novikoff, N R Chowdhury, J Whiting, A Reisner, J R Chowdhury.   

Abstract

Hepatocytes harvested by collagenase perfusion of rat liver were attached to collagen-coated microcarriers and injected intraperitoneally into congeneic or allogeneic bilirubin-UDP-glucuronosyltransferase (EC 2.4.1.17)-deficient (Gunn) rats or allogeneic analbuminemic (NAR) rats. Five days later, the microcarriers were observed to have formed conglomerates chiefly on the anterior surface of the pancreas. Scanning electron microscopy showed hepatocytes attached to the granular collagen-coated surface of the microcarriers and newly formed connective tissue. Light microscopy revealed that the microcarriers formed a lattice with the collagen tissue; hepatocytes were seen within this lattice or on the surface of the microcarriers. Hepatocyte plasma membranes were nucleoside-diphosphatase (NDPase)-positive. Newly formed blood islands, blood vessels containing erythrocytes and leukocytes and NDPase-positive endothelium were observed in close proximity to the hepatocytes and fibroblasts. Transmission electron microscopic examination showed hepatocytes with microvilli and nucleoid-containing peroxisomes with catalase activity. Hepatocytes were present for up to 2 months in congeneic recipients, the longest period of observation after transplantation. After normal microcarrier-attached hepatocytes were transplanted into allogeneic Gunn rats, bilirubin glucuronides were present in bile for 6 days. When congeneic Gunn rat recipients were used, bilirubin glucuronides were present in bile throughout the study (28 days); this was accompanied by reduction of serum bilirubin concentrations to nearly normal levels. After injection of normal hepatocytes into allogeneic NAR rats, plasma albumin concentration progressively increased for 6 days and then declined. In NAR recipients which were immunosuppressed with cyclosporin A, peak plasma albumin levels were reached in 14 days and persisted nearly at that level throughout the study (28 days).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429307      PMCID: PMC386741          DOI: 10.1073/pnas.83.19.7475

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Cytochemical contributions to differentiating GERL from the Golgi apparatus.

Authors:  A B Novikoff; P M Novikoff
Journal:  Histochem J       Date:  1977-09

2.  Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.

Authors:  B G Sommer; D E Sutherland; A J Matas; R L Simmons; J S Najarian
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Immunologic response to liver cell allografts.

Authors:  L H Toledo-Pereyra; D A Gordon; G H MacKenzie
Journal:  Am Surg       Date:  1982-01       Impact factor: 0.688

5.  Heterogeneity of bile pigment conjugates as revealed by chromatography of their ethyl anthranilate azopigments.

Authors:  K P Heirwegh; G P Van Hees; P Leroy; F P Van Roy; F H Jansen
Journal:  Biochem J       Date:  1970-12       Impact factor: 3.857

6.  Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1.

Authors:  L Makowka; L E Rotstein; R E Falk; J A Falk; R Zuk; B Langer; L M Blendis; M J Phillips
Journal:  Can J Surg       Date:  1981-01       Impact factor: 2.089

7.  Treatment of enzyme deficiency by hepatocyte transplantation in rats.

Authors:  J P Vroemen; N Blanckaert; W A Buurman; K P Heirwegh; G Kootstra
Journal:  J Surg Res       Date:  1985-09       Impact factor: 2.192

8.  Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation.

Authors:  L Makowka; L E Rotstein; R E Falk; J A Falk; B Langer; N A Nossal; L M Blendis; M J Phillips
Journal:  Surgery       Date:  1980-08       Impact factor: 3.982

9.  Distribution of peroxisomes (microbodies) in the nephron of the rat: a cytochemical study.

Authors:  M E Beard; A B Novikoff
Journal:  J Cell Biol       Date:  1969-08       Impact factor: 10.539

10.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

View more
  17 in total

Review 1.  Cellular transplantation and gene therapy.

Authors:  C Ricordi; S T Ildstad; T E Starzl
Journal:  Clin Transplant       Date:  1993-02       Impact factor: 2.863

2.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice.

Authors:  C Ricordi; Y Zeng; A Tzakis; R Alejandro; A J Demetris; J Fung; D R Bereiter; D H Mintz; T E Starzl
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

Review 4.  Hepatocyte transplantation. A potential treatment for liver disease.

Authors:  A A Demetriou; A Felcher; A D Moscioni
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

5.  Microcarrier-attached rat hepatocytes as a xenobiotic-metabolizing system in cocultures.

Authors:  J U Voss; H Seibert
Journal:  Cell Biol Toxicol       Date:  1991-10       Impact factor: 6.691

6.  Adult rat hepatocyte microcarrier culture. Comparison to the conventional dish culture system.

Authors:  A Athari; K Unthan-Fechner; P Schwartz; I Probst
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

7.  Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions.

Authors:  F D Ledley; G J Darlington; T Hahn; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo.

Authors:  J A Thompson; C C Haudenschild; K D Anderson; J M DiPietro; W F Anderson; T Maciag
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 9.  Engineered liver for transplantation.

Authors:  Basak E Uygun; Martin L Yarmush
Journal:  Curr Opin Biotechnol       Date:  2013-06-20       Impact factor: 9.740

Review 10.  Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells.

Authors:  David A Shafritz; Michael Oertel
Journal:  Int J Biochem Cell Biol       Date:  2010-01-18       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.